mizetam 10 mg + 40 mg tabletki
zakłady farmaceutyczne polpharma s.a. - ezetimibum + atorvastatinum calcicum trihydricum - tabletki - 10 mg + 40 mg
mizetam 10 mg + 80 mg tabletki
zakłady farmaceutyczne polpharma s.a. - ezetimibum + atorvastatinum calcicum trihydricum - tabletki - 10 mg + 80 mg
torvazin plus 10 mg + 10 mg kapsułki twarde
egis pharmaceuticals plc - atorvastatinum calcicum trihydricum + ezetimibum - kapsułki twarde - 10 mg + 10 mg
torvazin plus 20 mg + 10 mg kapsułki twarde
egis pharmaceuticals plc - atorvastatinum calcicum trihydricum + ezetimibum - kapsułki twarde - 20 mg + 10 mg
torvazin plus 40 mg + 10 mg kapsułki twarde
egis pharmaceuticals plc - atorvastatinum calcicum trihydricum + ezetimibum - kapsułki twarde - 40 mg + 10 mg
tulip combo 10 mg + 80 mg tabletki powlekane
sandoz gmbh - ezetimibum + atorvastatin calcium trihydrate - tabletki powlekane - 10 mg + 80 mg
tulip combo 10 mg + 10 mg tabletki powlekane
sandoz gmbh - ezetimibum + atorvastatin calcium trihydrate - tabletki powlekane - 10 mg + 10 mg
tulip combo 10 mg + 40 mg tabletki powlekane
sandoz gmbh - ezetimibum + atorvastatin calcium trihydrate - tabletki powlekane - 10 mg + 40 mg
tulip combo 10 mg + 20 mg tabletki powlekane
sandoz gmbh - ezetimibum + atorvastatin calcium trihydrate - tabletki powlekane - 10 mg + 20 mg
ebvallo
pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.